Telix Pharmaceuticals (TLX.AU) Q1 2022 Earnings

24JanConfirmed
Q3 2020
Q1 2021
Q3 2021
Q1 2022
-0.17
-0.14
-0.1
-0.07

Details

Expected EPS
N/A
Actual EPS
-0.17
Surprise EPS
-0.17
Surprise Percent
+∞%

Description

Telix Pharmaceuticals (TLX.AU) has reported earnings of -0.17 per share for Q1 2022.

0 Comments

Share your thoughts